Genelex associate lab director follows life-long passion for pharmacogenetics research

As a 12 year-old-boy in India, Ranjit Thirumaran, M.Pharm, PhD, saw the toll adverse drug reactions can take firsthand. Following hospitalization after a minor accident, his uncle suddenly died, likely due to an adverse drug reaction from a recently administered dose of warfarin. “I was always curious: Could something have been done to save him?” said Dr. Thirumaran, Genelex’s associate … Read More

Gauging the IMPACT of pharmacogenetic testing

Update: The results of this research are in! Find out more here. How can pharmacogenetic testing improve care for elderly patients taking multiple medications? Genelex is trying to find out. As a pioneer in the field of personalized medicine, Genelex, the creators of the YouScript Personalized Prescribing System, is continually investigating ways to further research on the benefits of pharmacogenetic … Read More

Medicare coverage for specific tests ends June 22

After June 21, Medicare will limit coverage for the core drug-sensitivity genetic tests that comprise YouScript’s Polypharmacy test panel. This means that if you or a loved one are 65 or older and not taking the drugs Plavix, nortriptyline, amitriptyline or Xenazine, you will lose this Medicare benefit.  Drug-sensitivity testing, also called pharmacogenetic testing, allows your doctor to know how your … Read More

Genelex-sponsored research awarded at managed care pharmacy conference

Recent research sponsored by Genelex and undertaken by University of Utah researchers has been recognized at the national Academy of Managed Care Pharmacy (AMCP) conference. The research shows that as many as 50 percent of patients 65 and older are taking at least one medication metabolized by a genetically variable drug metabolizing enzyme. The poster for this work, co-presented by Genelex … Read More

Genelex announces new genetic testing options

Genelex is excited to announce the next chapter in the company’s ongoing mission to improve patient care and reduce adverse drug events. Genelex is unveiling five new panels and 17 new genetic testing options to augment our existing panel of six tests that form the core of the YouScript Personalized Prescribing System. In conjunction with the YouScript Personalized Prescribing software, … Read More